CVS Health Corporation $CVS Stock: Vise Technologies Inc. Raises Position

Vise Technologies Inc. lifted its holdings in CVS Health Corporation (NYSE:CVS) by 27.7% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 75,195 shares of the pharmacy operator’s stock after acquiring an additional 16,303 shares during the quarter. Vise Technologies Inc.’s holdings in CVS Health were worth $6,443,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. Kilter Group LLC acquired a new stake in shares of CVS Health during the 2nd quarter valued at $27,000. Beaird Harris Wealth Management LLC increased its stake in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares during the last quarter. J.Safra Asset Management Corp acquired a new position in shares of CVS Health in the second quarter worth $30,000. Timbuktu Capital Management LLC purchased a new stake in shares of CVS Health during the second quarter worth $31,000. Finally, Dunhill Financial LLC purchased a new stake in shares of CVS Health during the second quarter worth $32,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CVS has been the topic of a number of recent research reports. Leerink Partners lowered their target price on CVS Health from $119.00 to $112.00 and set an “outperform” rating on the stock in a research note on Monday, October 12th. UBS Group reaffirmed a “buy” rating on shares of CVS Health in a research report on Tuesday, September 22nd. BMO Capital Markets set a $112.00 price target on CVS Health in a research note on Wednesday, September 9th. Cantor Fitzgerald reiterated a “neutral” rating on shares of CVS Health in a report on Friday, October 9th. Finally, Wall Street Zen cut CVS Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 19th. Nineteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $109.64.

CVS Health Trading Down 1.9%

Shares of CVS stock opened at $88.54 on Tuesday. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $91.13 and its two-hundred day moving average is $88.80. The company has a market cap of $113.24 billion, a PE ratio of 23.42, a price-to-earnings-growth ratio of 0.84 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. During the same period in the previous year, the company earned $1.81 earnings per share. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were issued a $0.6650 dividend. This represents a $2.66 annualized dividend and a yield of 3.0%. The ex-dividend date was Thursday, October 22nd. CVS Health’s dividend payout ratio (DPR) is 70.37%.

About CVS Health

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.